Holders — by stockHoldings — by fund
Nextech Invest Ltd.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001595430
$2.11B
disclosed book value
15
positions
67.6%
largest position share
Positions, as of 2026-06-30
top 16 of 15 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 7.6M | $1.42B | 67.6% |
| 2 | PBLSPARABILIS MEDICINES INC | 4.7M | $127.6M | 6.1% |
| 3 | RLAYRELAY THERAPEUTICS INC | 6.8M | $126.8M | 6% |
| 4 | TYRATYRA BIOSCIENCES INC | 3.6M | $113.5M | 5.4% |
| 5 | ALMSALUMIS INC | 3.5M | $99.6M | 4.7% |
| 6 | ORICORIC PHARMACEUTICALS INC | 7.2M | $77.6M | 3.7% |
| 7 | KYMRKYMERA THERAPEUTICS INC | 278,896 | $32.0M | 1.5% |
| 8 | ZYMEZYMEWORKS INC | 1.1M | $29.1M | 1.4% |
| 9 | GLUEMONTE ROSA THERAPEUTICS INC | 761,153 | $18.4M | 0.9% |
| 10 | CTMXCYTOMX THERAPEUTICS INC. | 4.4M | $16.7M | 0.8% |
| 11 | ARVNAVALO THERAPEUTICS INC | 766,000 | $14.2M | 0.7% |
| 12 | SLNSILENCE THERAPEUTICS PLC | 952,400 | $10.5M | 0.5% |
| 13 | CRVSCORVUS PHARMACEUTICALS INC | 450,000 | $6.7M | 0.3% |
| 14 | CNTXCONTEXT THERAPEUTICS INC | 7.4M | $4.1M | 0.2% |
| 15 | ENGNENGENE THERAPEUTICS INC | 2.3M | $4.0M | 0.2% |
| 16 | ARVNARVINAS INC | 356,713 | $3.0M | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.